[1]BMI1 regulates multiple myeloma-associated macrophage's pro-myeloma functions. [2]Pathogenesis and treatment of multiple myeloma. [3]Efficacy and safety of pomalidomide and low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: a multicenter, prospective, single-arm, phase 2 trial [4]Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma. [5]RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor [6]多发性骨髓瘤疾病全周期健康管理 [7]Advances in research on potential inhibitors of multiple myeloma [8]Heme oxygenase-1 attenuates the inhibitory effect of bortezomib against the APRIL-NF-κB-CCL3 signaling pathways in multiple myeloma cells: Corelated with bortezomib tolerance in multiple myeloma. [9]A compound chimeric antigen receptor strategy for targeting multiple myeloma. [10]多发性骨髓瘤小鼠模型构建的研究进展